Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 7.002% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) CCOP(C)(=S)SCC(=O)NC(C)C(=O)O
b) CCC(C)NS(=O)(=O)c1ccc(OCC(=O)NCc2cccnc2)cc1
c) CCC(=O)Nc1ccc(NC(=S)NC(=O)c2oc3ccccc3c2C)cc1
Answer: c. CCC(=O)Nc1ccc(NC(=S)NC(=O)c2oc3ccccc3c2C)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1ccc(NC(=S)NC(=O)c2oc3ccccc3c2C)cc1
CCC(=O)Nc1ccc(NC(=S)NC(=O)c2oc3ccccc3c2C)cc1
3-methyl-N-[[4-(propanoylamino)phenyl]carbamothioyl]-1-benzofuran-2-carboxamide